Raymond Huml | Vice President, Rare & Orphan Strategy
Sciensus

Dr. Raymond A. Huml is the Vice President of Rare Disease Strategy at Sciensus, with over 30 years in the healthcare and biopharmaceutical industries. A leader in rare disease research and global due diligence, he has driven nearly $3 billion in capital commitments. A prolific author and award-winning expert, he is dedicated to advancing rare disease innovation, diversity, and global healthcare, including his Peace Corps service in Ghana.